Business news for the stock market

Nexus AG: majority owned subsidiary "ifa systems AG" acquires 80% in leading ophthalmology patient platform "Sophrona" in the USA

Donaueschingen (pta020/03.11.2020/12:08 UTC+1) Acquisition opens up further growth potential for ifa and NEXUS in the USA and in Europe
- State-of-the-art open-standard technologies and API
- Adds Patient Portal, Referral Portal and Partner Portal as new products

ifa systems AG acquires -through its US-subsidiary - an 80 percent majority stake in Sophrona Solutions, Inc. based in North Oaks, Minnesota (USA), with effect from October 31, 2020. With almost 2,000 installations, Sophrona is a leading portal platform in the USA for online communication between patients and doctors in ophthalmology. Practices and clinics increase their efficiency and patient retention by using these solutions. Sophrona has already been leading the market in ophthalmology in USA for over a decade and will strengthen the competitive position of ifa and NEXUS in Europe further.

NEXUS holds 52.6% of IFA AG and is sharing a joint ophthalmology software-strategy on the international markets.

"With this acquisition, we continue to implement our platform strategy and invest in our planned growth", says Jörg Polis, CEO of ifa systems AG. "ifa's software is designed to efficiently support workflows in ophthalmology and their administrative and medical documentation in the patient record. It is necessary to integrate hardware and software from other providers in ophthalmology", says Jörg Polis, CEO of ifa systems AG.

Marc-François Bradley, founder and President of Sophrona, says: "ifa and Sophrona share the same philosophy: customer success means a commitment to open platforms and collaboration with other vendors. We have proven this works in our existing partnership and look forward to also building on this relationship model internationally."

ifa currently serves its USA practices and clinics customers from two US locations. The acquisition will significantly expand ifa's presence in the American market and create new growth potential. At the same time, Sophrona will gain access to the European market for its open solutions. "The technological standards of Sophrona's products are groundbreaking for ifa ", says Polis. "We see great opportunities to support German and European customers on their way to a real patient portal. Sophrona is an important addition for ifa as the competence center for ophthalmology within NEXUS group."

Sophrona generated revenues of USD 1.6 million in 2019, mainly as Software-as-a-Service contracts.


Emitter: Nexus AG
Irmastraße 1
78166 Donaueschingen
Contact Person: Hannes Wehinger
Phone: +49 771 - 22960 258
ISIN(s): DE0005220909 (Share)
Stock Exchange(s): Regulated Market in Frankfurt, Hamburg; Free Market in Berlin, Dusseldorf, Munich, Stuttgart